Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06060119
Other study ID # KCDSHEC/IP/2022/S21
Secondary ID
Status Not yet recruiting
Phase Phase 2
First received
Last updated
Start date November 28, 2023
Est. completion date July 30, 2024

Study information

Verified date September 2023
Source Krishnadevaraya College of Dental Sciences & Hospital
Contact ANUSHA S, MDS
Phone 7204759280
Email sanusha097@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The presence study is toComparison of Microneedling with Subepithelial Connective Tissue Auto Graft for Gingival Augmentation- A Randomized Case Control Trial. The trial is in accordance with the Consolidated Standards of Reporting Trials (CONSORT) criteria, 2010.


Description:

The periodontal phenotype previously called as biotype is a reflection of gingiva and buccal bone thickness. It is a vital clinical parameter as it will determine whether there will be recession , dehiscence and fenestration or pocket formation.1Basically gingival epithelium provides a physical barrier to infection and protects the deeper structures thus, the gingival phenotype has major impact on the outcome of the restorative, regenerative, implant and orthodontic therapy.2 Common causes of recession are faulty toothbrushing ,tooth malposition, abnormal frenum attachment, trauma from occlusion and orthodontic tooth movement in labial direction.2 Gingiva can be classified as thick > 1mm and thin < 1mm according to recent 2017 world work shop classification.3 Traditionally, gingival augmentation is achieved using free gingival graft, connective tissue graft, soft tissue substitutes. Subepithelial connective tissue auto graft is still the gold standard. All of these technique's are invasive, complicated, technique senstive and do not have cost efficiency4, thus there is an on going reasearch for a more simpler non invasive method to increase gingival thickness. Microneedling also knows as "percutaneous collagen induction therapy" is a novel and innovative method to thicken gingiva.5It involves creating several microinjuries in the form of inducing superficial bleeding points there by inducing a wound healing cascade which releases a few key soft tissue growth factor's such as platelet-derived growth factors, transforming growth factors, connective tissue growth factor and fibroblast growth factors.1 Fernandes has developed a percutaneous technology based on principals of microneedling to initiate natural post traumatic inflammatory reaction by using microneedles.6 The growthfactor's thus released post injury stimulate proliferation of new cells and transformation of fibroblast into collagen and elastin fiber, starting from 5th day up to 8th week. Newly formed fibers thicken the tissue during the process known as neocollagenesis. Fibroblasts also trigger neoangiogenesis by accelerating the proliferation of endothelial cells in the blood vessels. The tissue remodeling changes continue from 8 weeks up to 1 year.7 Thus, this non-invasive technique of microneedling will be compared to the time tested subepithelial connective tissue autograft to obtain a deeper insight over its feasibility.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 12
Est. completion date July 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Patients > 18 years of age. - Patients with esthetic concern . - Patient under going orthodontic, prosthodontic, restorative treatment where thick gingiva is necessary. - Systemically healthy subjects - Full mouth plaque index,full mouth bleeding on probing score < or = 15 - Patient with palatal mucosa greater than 4mm Exclusion Criteria: - Previous periodontal surgery - Patients with history of coagulation disorder - Smoking habit - Pregnant and lactating females - Use of any

Study Design


Related Conditions & MeSH terms


Intervention

Device:
microneedling
The operative sites will be anaesthetized with 2% lignocaine hydrochloride with adrenaline(1:80,000).Electric microneedling pen device model THAPPINKTM is used. Microneedling is carried out on the isolated site involving one tooth mesially and distally and 1.5mm apical to marginal gingiva each for 30-40 second intermittently. When pin point bleeding observed on the area of gingiva it is irrigated with sterile saline solution. Patient will be instructed to refrain from consuming hot beverage and brushing in that area for one day to avoid mechanical trauma. A total of 4 session of micro needling procedure will be carried out in one subject at 10 days intervals upto 40days

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Krishnadevaraya College of Dental Sciences & Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary OBJECTIVES OF THE STUDY: The primary outcomes measured will be : 1) Increase in gingival augmentation with microneedling Increase in gingival augmentation with microneedling will be measured in (mm)
Comparison of microneedling with subepithelial connective tissue graft for gingival thickness in(mm) digital calliper and spreader file
6 months
Secondary thickness in mm Increase KTW (keratinization tissue width) will be checked in digital calliper and spreader file 6 months
See also
  Status Clinical Trial Phase
Completed NCT04690140 - Can Modified Coronally Advanced Tunnel be an Alternative in Gingival Phenotype Modification? N/A
Recruiting NCT05706480 - Assessment of Gingival Thickness Using Colored Periodontal Probe